Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 2 EP applications Teyrnon Cei Jones has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 27, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14710617

COMBINATION TREATMENT

IPC classification:
A61K 31/337, A61K 31/5377, A61P 35/00
Applicant:
AstraZeneca AB
Agent:
Teyrnon Cei Jones, AstraZeneca PLC
Status:
EXAMINATION REQUESTED
EP15724351

IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
AstraZeneca AB
Agent:
Teyrnon Cei Jones, AstraZeneca AB
Agent:
Teyrnon Cei Jones, AstraZeneca PLC
Status:
The patent has been granted

Please Sign in to use this feature